SecBot SecBot
6-K ·Filed Sep 18, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001654954-26-008442
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine employee share scheme admission with no price impact. Monitor upcoming quarterly results for operational trends and any activist engagement updates from Cevian Capital.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$27.56
T+0 close · Sep 18, 2026 · via day close
Latest settled
+5.44%
T+20 · $29.06 · next T+60 in 27d
Vs SPY
+5.24%
α at T+20
Latest observation
+13.71%
T+38 · FF3 residual α
  1. T+0 · Sep 18 $27.56entry
  2. T+1 · 8w ago +0.47%α −1.08% · $27.69
  3. T+5 · 8w ago −2.36%α −3.63% · $26.91
  4. T+20 · 5w ago +5.44%α +5.24% · $29.06
  5. T+41 · todayOpen
  6. T+60 · in 27d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith & Nephew filed a 6-K reporting the admission of 16,274 ordinary shares to trading on the London Stock Exchange, issued under employee share schemes. This is a routine administrative notification with no material financial impact.

Key Facts

  • 16,274 ordinary shares of USD 0.20 each were admitted to trading on the London Stock Exchange Main Market.
  • Shares were issued under the company's employee share schemes from August 11, 2026 to September 7, 2026.
  • Total shares outstanding after admission: 877,750,024 ordinary shares, with 40,317,488 held in treasury.
  • The new shares are fully fungible with existing ordinary shares.

Financial Impact

Negligible, 16,274 shares represent approximately 0.002% of total outstanding shares, resulting in immaterial dilution.

dilution

Risk Factors

  • No material risks identified from this filing.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-008442
Document: 0001654954-26-008442-index-headers.html0001654954-26-008442
Document: 0001654954-26-008442-index.html0001654954-26-008442
Document: 0001654954-26-008442.txt0001654954-26-008442

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 18, 2026